Evidence map›Paper›PMID 38072870›Full record

ArticleAnnals of intensive care2023

Inhaled drug delivery: a randomized study in intubated patients with healthy lungs.

Jonathan Dugernier, Déborah Le Pennec, Guillaume Maerckx, Laurine Allimonnier, Michel Hesse, Diego Castanares-Zapatero, Virginie Depoortere, Laurent Vecellio, Gregory Reychler, Jean-Bernard Michotte and 7 more

Open access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. AnFrontiers in medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Jonathan Dugernier *Soins Intensifs, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium. Jonathan.dugernier@he-arc.ch.ORCID http://orcid.org/0000-0001-6567-8523
Déborah Le Pennec *Centre d'Etude des Pathologies Respiratoires, INSERM U1100, Faculté de médecine, Université de Tours, Tours, France.
Guillaume Maerckx *Soins Intensifs, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Laurine AllimonnierCentre d'Etude des Pathologies Respiratoires, INSERM U1100, Faculté de médecine, Université de Tours, Tours, France.
Michel HesseMédecine Nucléaire, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Diego Castanares-ZapateroSoins Intensifs, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Virginie DepoortereMédecine Nucléaire, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Laurent VecellioCentre d'Etude des Pathologies Respiratoires, INSERM U1100, Faculté de médecine, Université de Tours, Tours, France.
Gregory ReychlerInstitut de Recherche Expérimentale et Clinique (IREC), Pôle de Pneumologie, ORL et Dermatologie, Université Catholique de Louvain, 1200, Brussels, Belgium.
Jean-Bernard MichotteSchool of Health Sciences (HESAV), HES-SO, University of Applied Sciences and Arts of Western Switzerland, 1011, Lausanne, Switzerland.
Pierre GoffetteRadiologie Interventionnelle, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Marie-Agnes DocquierAnesthésiologie, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Christian RaftopoulosNeurochirurgie, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
François JamarMédecine Nucléaire, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Pierre-François LaterreSoins Intensifs, CHR Mons-Hainaut, 7000, Mons, Belgium.
Stephan Ehrmann *Centre d'Etude des Pathologies Respiratoires, INSERM U1100, Faculté de médecine, Université de Tours, Tours, France.
Xavier Wittebole *Soins Intensifs, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
Cliniques Universitaires Saint-Luc · BEUniversité de Tours · FRHES-SO University of Applied Sciences and Arts Western Switzerland · CHUniversity of Mons · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe administration technique for inhaled drug delivery during invasive ventilation remains debated. This study aimed to compare in vivo and in vitro the deposition of a radiolabeled aerosol generated through four configurations during invasive ventilation, including setups optimizing drug delivery.

methodsThirty-one intubated postoperative neurosurgery patients with healthy lungs were randomly assigned to four configurations of aerosol delivery using a vibrating-mesh nebulizer and specific ventilator settings: (1) a specific circuit for aerosol therapy (SCAT) with the nebulizer placed at 30 cm of the wye, (2) a heated-humidified circuit switched off 30 min before the nebulization or (3) left on with the nebulizer at the inlet of the heated-humidifier, (4) a conventional circuit with the nebulizer placed between the heat and moisture exchanger filter and the endotracheal tube. Aerosol deposition was analyzed using planar scintigraphy.

resultsA two to three times greater lung delivery was measured in the SCAT group, reaching 19.7% (14.0-24.5) of the nominal dose in comparison to the three other groups (p < 0.01). Around 50 to 60% of lung doses reached the outer region of both lungs in all groups. Drug doses in inner and outer lung regions were significantly increased in the SCAT group (p < 0.01), except for the outer right lung region in the fourth group due to preferential drug trickling from the endotracheal tube and the trachea to the right bronchi. Similar lung delivery was observed whether the heated humidifier was switched off or left on. Inhaled doses measured in vitro correlated with lung doses (R = 0.768, p < 0.001).

conclusionOptimizing the administration technique enables a significant increase in inhaled drug delivery to the lungs, including peripheral airways. Before adapting mechanical ventilation, studies are required to continue this optimization and to assess its impact on drug delivery and patient outcome in comparison to more usual settings.

Indexed as

Aerosol deliveryInvasive mechanical ventilationNebulizer

Identifiers

PMID38072870
PMCPMC10710976
OpenAlexW4389557453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.